Intervention

BPC-157

Last updated Sat May 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Pre-clinical— Animal data only; no human controlled trials

What it is

BPC-157 is a synthetic 15-amino-acid peptide derived from a sequence in human gastric juice ("Body Protection Compound"). Pre-clinical work (largely from one research group) reports accelerated healing of tendon, ligament, muscle, intestinal mucosa, and bone in rodent models, with very favourable safety profile in animals.

What we don’t know

No human RCTs. All published data are pre-clinical or anecdotal.
Optimal dose, route, duration in humans is guesswork.
Long-term safety in humans is uncharacterised.
Theoretical concerns about pro-angiogenic effects in occult cancers.

Supply-chain reality

BPC-157 is sold as a "research chemical not for human use" through unregulated suppliers. Contamination, mislabelling, and dose inaccuracy are common in this market. FDA has explicitly warned against compounded BPC-157.

If you're considering this

Work with a licensed clinician, not a website.
Ask for third-party assay certificates of the lot you receive.
Don’t use during pregnancy.
Avoid in known active cancer (theoretical pro-growth concern).
Understand you are participating in an uncontrolled n=1 experiment.

References

Sikiric, P. et al. Stable gastric pentadecapeptide BPC 157 and wound healing. Front. Pharmacol. 7, 217 (2016).